ERVIN GRAVES STRATEGY GROUP, LLC for EMERGENT BIOSOLUTIONS INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 19, 2018 | $30,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 24, 2018 | $30,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE COLAIEZZI | — |
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER | — |
Budget/Appropriations BUD
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE COLAIEZZI | — |
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER | — |
Homeland Security HOM
FY 2018 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government. Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense
| Lobbyist | Covered position, as disclosed |
|---|---|
| MADELEINE COLAIEZZI | — |
| JAMES L ERVIN | Chairman & CEO |
| COLBY MILLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.